Note 13 - Segment Information (Tables)

9 Months Ended

Mar. 31, 2021

Notes Tables

Schedule of Segment Reporting Information, by Segment [Table Text Block]

	Quarter Ended						Nine Months Ended
	March 31,						March 31,
	2021			2020			2021			2020
Net sales:
Protein Sciences	$	185,623		$	145,509		$	512,248		$	428,021
Diagnostics and Genomics		58,093			49,411			160,687			135,808
Intersegment		(164	)		(240	)		(931	)		(972	)
Consolidated net sales	$	243,552		$	194,680		$	672,004		$	562,857
Operating income:
Protein Sciences	$	88,392		$	65,046		$	238,991		$	185,456
Diagnostics and Genomics		10,417			7,062			27,197			8,937
Segment operating income	$	98,809		$	72,108		$	266,188		$	194,393
Costs recognized on sale of acquired inventory		(68	)		-			(91	)		-
Amortization of acquisition related intangible assets		(15,222	)		(15,459	)		(45,750	)		(45,467	)
Acquisition related expenses		(1,731	)		322			(6,289	)		(107	)
Stock based compensation, inclusive of employer taxes		(11,968	)		(8,088	)		(41,525	)		(27,505	)
Restructure costs		-			-			(142	)		-
Corporate general, selling, and administrative expenses		(1,194	)		(1,092	)		(3,677	)		(3,205	)
Consolidated operating income	$	68,626		$	47,791		$	168,714		$	118,109